Provider
QP25-25 MHCP Pharmacy Benefit Exclusion for Datroway®, Frindovyx™, Kebilidi™ and Niktimvo™
Program effective Date: Mar 12, 2025
Documents & Forms Results
Displaying 2651 - 2660 of 3642 results
Provider
QP24-25 Commercial Pharmacy Benefit Exclusion for Octreotide Kit, Sandostatin® Kit LAR, and Signifor® LAR injection
Program effective Date: Mar 12, 2025
Provider
QP23-25 Commercial Pharmacy Benefit Exclusion for Kebilidi™, Niktimvo™, Steqeyma® and Yesintek™
Program effective Date: Mar 12, 2025
Provider
QP22-25 Provider Press: Q1 2025
Program effective Date: Mar 12, 2025
Provider
QP21-25 Appropriate Use of Modifier -25
Program effective Date: Mar 12, 2025
Provider
QP30-25 Accurate Place of Service on Claim Submission
Program effective Date: Mar 26, 2025
Provider
2023 Prior Authorization approvals and appeals statistics — Blue Cross Plans
Prior Authorizations for Services Provided from January 1, 2023 to December 31, 2023 — Blue Cross Plans